• Pharma
  • May 14, 2025
  • 388 views
India’s anti-obesity drug market quadruples in five years on lifestyle disease surge

India’s anti-obesity drug market has grown more than fourfold in the last five years fuelled by rising instances of lifestyle diseases along with greater affordability and willingness among a section…

  • Pharma
  • March 21, 2025
  • 496 views
Popular diabetes drug, Mounjaro, launched in India

Mounjaro (tirzepatide): A breakthrough drug for the treatment of Type 2 diabetes and obesity, has been released in India. The drug has been approved by the Central Drugs Standard Control Organization…

  • Pharma
  • February 12, 2025
  • 709 views
Pharma companies turn to AI to speed up drug development, but hit hurdles

When Genentech licensed experimental drug vixarelimab from Kiniksa Pharmaceuticals, its scientists thought they had a future lung medicine in their hands. Artificial intelligence came up with another plan. It was…